Consistently, WSB2 expression at the mRNA level was positively associated with poor survival in HCC patients in the TCGA HCC cohort (http://gepia.cancer-pku.cn/, Supplementary Fig. 3g, h). Here, WSB2 is linked to hepatocellular carcinoma.